Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NACT vs Concurrent Chemoradiation in Cervical Cancer
NCT00193739Phase 3Unknown
- Sponsor
- Tata Memorial Hospital
- Start
- Sep 2003
- Primary completion
- Jul 2020
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of paclitaxel and carboplatin in Cervical Cancer (CC) (2 arms), sponsored by Tata Memorial Hospital. Primary endpoint: Disease Free Survival at 5 years. Status: unknown.
02
Drugs
paclitaxelcarboplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00193739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00193739.